FLUZONE Quadrivalent - Sanofi Pasteur
Sanofi Pasteur Section Product Monograph 450/477 - FLUZONE Quadrivalent Page 1 of 35 PRODUCT MONOGRAPH FLUZONE Quadrivalent Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion) Suspension for Injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07B B Manufactured by: Sanofi Pasteur Limited Toronto, Ontario, Canada Fabricated by: Date of Revision: April 2017 Sanofi Pasteur Inc. Swiftwater, PA 18370 USA Control #: 204591 Date Approved: April 13, 2017Sanofi Pasteur Section Product Monograph 450/477 - FLUZONE Quadrivalent Page 2 of 35 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION.
Sanofi Pasteur Section 1.3.1 Product Monograph 450/477 - FLUZONE® Quadrivalent Page 3 of 35 Study Demographics and Trial Design.....15
Download FLUZONE Quadrivalent - Sanofi Pasteur
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
FOR THE TREATMENT OF, For the Treatment of Hemophilia and von Willebrand Disease, Program: What Your Practice, Program: What Your Practice & Hospital Need, GUIDELINES FOR THE MANAGEMENT OF, Guidelines for the Management of Hemophilia, Guidelines, World, Of Hemophilia, PRESCRIBING INFORMATION, ALPROLIX, Food and Drug